Intralytix, Inc. was founded in 1998 to address growing problems in the control and treatment of disease-causing bacteria. These problems are presently compounded by the overuse of traditional chemical antibiotics along with the lack of new potent antibiotics and the reluctance of the public to employ new and potentially hazardous chemical agents or solutions formulated through recombinant technology. Intralytix is using its core bacteriophage technology to develop novel natural products for use in food processing, environmental clean-up, sanitation, consumer products, and problems of antibiotic resistance in human therapy.